These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Use of a benziodarone, a coronary vasodilator, in the treatment of ambulatory coronary patients]. Parenti B; De Micheli E Clin Ter; 1969 Jan; 48(2):157-70. PubMed ID: 5404643 [No Abstract] [Full Text] [Related]
24. [Imolamine in acute coronary insufficiency. Some considerations in the light of 30 treated cases]. Caporicci D Clin Ter; 1977 Mar; 80(6):553-85. PubMed ID: 862356 [No Abstract] [Full Text] [Related]
25. [Photometry of retinal vessels following administration of vasodilator agents]. Ogielska E; Baran L Klin Oczna; 1972; 42(1):115-8. PubMed ID: 5019223 [No Abstract] [Full Text] [Related]
26. [Effect and benefit of afterload reduction in coronary heart disease]. Lossnitzer K Med Klin (Munich); 1987 Jan; 1():9-14. PubMed ID: 3472032 [No Abstract] [Full Text] [Related]
29. [Cardioprotective effects of a new fluorine-containing synthetic activator of ATP-dependent potassium channels]. Strutyns'kyĭ RB; Moĭbenko OO; Iahupol's'kyĭ LM; Iuz'kiv MIa; Kvochina LI; Shysh AM Fiziol Zh (1994); 2001; 47(2):16-23. PubMed ID: 11392109 [TBL] [Abstract][Full Text] [Related]
30. [Treatment of chronic coronary insufficiency by local perfusion of the coronary vessels with vasodilators and Rheomacrodex]. Marti WK; Essinger A Praxis; 1966 Sep; 55(35):971-4. PubMed ID: 5953219 [No Abstract] [Full Text] [Related]
31. [Comparative effectiveness of phenicaberan and carbochromen in ischemic heart disease]. Todosienko LA Vrach Delo; 1980 Aug; (8):51-5. PubMed ID: 7415129 [No Abstract] [Full Text] [Related]
32. [The clinical effect of Crataegutt in heart disease of ischemic or hypertensive origin. A multicenter double-blind study]. Iwamoto M; Sato T; Ishizaki T Planta Med; 1981 May; 42(1):1-16. PubMed ID: 7019949 [No Abstract] [Full Text] [Related]
33. [Use of calcium antagonists in ophthalmology]. Pillunat LE Klin Monbl Augenheilkd; 1996 Jun; 208(6):A1-2. PubMed ID: 8965456 [No Abstract] [Full Text] [Related]
34. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin]. Kolomoets NM; Baksheev VI; Uvaĭsova KU Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710 [TBL] [Abstract][Full Text] [Related]
35. [Can the Doppler method indicate the usefulness of vasodilator therapy?]. Bartolo M; Antignani PL Recenti Prog Med; 1981 Aug; 71(2):175-84. PubMed ID: 7313287 [No Abstract] [Full Text] [Related]
36. [Reaction of the retinal vascular system to basic vasodilator substances after long-term administration to various sites]. Bryk E Folia Med Cracov; 1986; 27(1-2):9-19. PubMed ID: 3732961 [No Abstract] [Full Text] [Related]
37. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial. Imre G; Németh B Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137 [No Abstract] [Full Text] [Related]
38. [Experiences with the coronary drug carduben]. Thönelt K Z Allgemeinmed; 1970 Nov; 46(32):1618-21. PubMed ID: 5512832 [No Abstract] [Full Text] [Related]
39. Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure. Hillier C; Petrie MC; Love MP; Johnston F; MacLean MR; McMurray JJ Clin Sci (Lond); 2001 Jul; 101(1):45-51. PubMed ID: 11410113 [TBL] [Abstract][Full Text] [Related]
40. [Report on the clinical testing of Cormelian-Digotab]. Pollter J Med Welt; 1974 Nov; 25(48):2015-21. PubMed ID: 4617836 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]